scispace - formally typeset
T

Thomas M. Marti

Researcher at University of Bern

Publications -  88
Citations -  3043

Thomas M. Marti is an academic researcher from University of Bern. The author has contributed to research in topics: Cancer & Peptide sequence. The author has an hindex of 27, co-authored 71 publications receiving 2683 citations. Previous affiliations of Thomas M. Marti include Bernhard Nocht Institute for Tropical Medicine & University of Zurich.

Papers
More filters
Journal ArticleDOI

H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks

TL;DR: It is shown that in contrast to ionizing radiation, UV irradiation mainly induces H2AX phosphorylation as a diffuse, even, pan-nuclear staining and plays a larger role in UV-induced signal transduction than previously realized.
Journal ArticleDOI

DNA mismatch repair and mutation avoidance pathways.

TL;DR: MMR‐independent pathways or factors that can process some types of mismatches in DNA are nucleotide‐excision repair (NER), some base excision repair (BER) glycosylases, and the flap endonuclease FEN‐1.
Journal ArticleDOI

Isolation, characterization and amino-acid sequence of gamma-seminoprotein, a glycoprotein from human seminal plasma.

TL;DR: γ-Seminoprotein (γ-SM) is a glycoprotein from human seminal plasma, which was isolated in highly purified form by ion-exchange chromatography on a Mono Q column as mentioned in this paper.
Journal ArticleDOI

Refolding of bacteriorhodopsin from expressed polypeptide fragments

TL;DR: The combined data show that the specificity of the helix assembly of bacteriorhodopsin is influenced by connectivities provided by the C-D and E-F surface loops, and the covalent connections in each of the six interhelical loops are dispensable for a correct association of the helices.
Journal ArticleDOI

Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin

TL;DR: In normal cells, serum starvation in vitro induces a cell cycle arrest and protects from CDDP induced toxicity and has the potential to enhance the therapeutic index of cisplatin-based therapy.